13G Filing: Rosalind Advisors, Inc. and Zosano Pharma Corp (NASDAQ:ZSAN)

Page 7 of 9 – SEC Filing

         
CUSIP No. 98979H103   13
G/A
  Page
7 of 9 Pages
         
Item 3. If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  (a) o Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
  (b) o Bank as defined
in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) o Insurance company
as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) o Investment company
registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) o An investment
adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
  (f) o An employee benefit
plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) o A parent holding
company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
  (h) o A savings associations
as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) o A church plan
that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3);
       
  (j) o Group, in accordance
with §240.13d-1(b)(1)(ii)(J).
       
Item 4. Ownership.

Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.

         
  (a)  

Amount
beneficially owned:  

 

Rosalind Master Fund
L.P. is the record owner of 220,761 shares, and warrants to acquire 364,000 shares of common stock.

Rosalind Capital Partners
L.P. is the record owner of 562,339 shares, and warrants to acquire 936,000 shares of common stock

Rosalind
Advisors, Inc. is the investment advisor to RCP and RMF and may be deemed to be the beneficial owner of shares held by
RCP and RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares
held by RCP and RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.

         
  (b)  

Percent
of class:  

Rosalind
Advisors, Inc. – 5.5%

Rosalind
Master Fund L.P. – 1.6%

Rosalind
Capital Partners L.P. – 4.0%

Steven
Salamon – 5.5%

         

Follow Zosano Pharma Corp (NASDAQ:ZSAN)